逸仙电商 (YSG.US) 2025年第四季度业绩电话会
文章语言：
简
繁
EN
Share
Minutes
原文
会议摘要
Investor Relations Manager led the earnings call, announcing a 20.1% year-over-year increase in total net revenue for Q4 2025, driven by a 51.9% increase in skincare brand revenues. The company achieved non-GAAP net income, showcasing improved profitability. Strategy focused on RD-led innovation, brand equity, and profitability enhancement was emphasized. Plans to grow the skincare business with higher margins and improve net profit margin through RD capabilities and operational efficiencies were outlined. The call ended with a Q&A session and an invitation for further inquiries.
会议速览
Yachts Earnings Call: Fourth Quarter and Full Year 2025 Financial ReviewA conference call discusses the financial results for the fourth quarter and full year 2025, focusing on earnings and performance metrics, as presented by the investor relations manager.
Forward-Looking Statements and Non-GAAP Measures in Corporate Earnings CallA company discusses forward-looking statements and non-GAAP financial measures, highlighting risks and uncertainties affecting future performance. Management outlines the use of non-GAAP measures for comparison purposes and references risk factors in the company's filings with the Securities and Exchange Commission.
Strong Q4 & FY2025 Financial Performance in China's Competitive Beauty MarketThe company achieved a 20.1% year-over-year revenue growth in Q4, with skincare brands driving 61.1% of total net revenues. Full-year revenue increased by 26.7%, reaching RMB 4.8 billion, while profitability improved significantly, narrowing the net loss margin to 2.2% and achieving non-GAAP profitability of 0.2%. This success highlights the effectiveness of strategic initiatives amid a competitive beauty market.
2035: Driving Innovation, Brand Equity, and Profitability in the Beauty IndustryThe year was marked by leveraging RD infrastructure for product innovation, deepening brand value through consumer insights, and enhancing profitability through operational excellence, resulting in a comprehensive growth strategy.
Commitment to Brand Equity Growth Through Innovation and QualityEmphasizes long-term strategy focusing on innovation and quality to enhance brand equity, with a transition to financial clarifications.
2025 Q4 & Annual Financial Results: Revenue Growth, Expense Management, and Improved ProfitabilityNet revenues rose by 20.1% in Q4 2025, driven by a 51.9% increase in skincare brand sales. Gross profit increased by 20%, maintaining a 77.7% margin. Operating expenses as a percentage of revenues dropped significantly, with R&D and marketing expenses rising due to increased competition and headcount. Full-year revenues grew by 26.7%, leading to a substantial decrease in operating and net loss margins, marking improved profitability. Cash flow usage increased in Q4 but remained manageable for the year. The outlook predicts a 15%-30% year-over-year revenue increase for the upcoming period.
Strategies for Enhancing Profit Margins and Expanding Skincare PortfolioDiscussed plans to improve net profit margins by focusing on high-margin skincare growth and leveraging R&D for product innovation, addressing portfolio expansion strategies for skincare brands.
Conference Concludes with Invitation for Further Inquiries and Appreciation for AttendeesThe session ends with an invitation to reach out for additional questions, appreciation for the audience's participation, and directions on how to contact the company for investor relations matters, followed by a polite farewell.
要点回答
Q：How has the company capitalized on its strategy initiatives and industry momentum?
A：The company has capitalized on the industry's momentum by successfully executing strategy initiatives, particularly in product innovation, brand equity, and profitability enhancement.
Q：What is the growth rate of China's beauty retail sales for the fourth quarter and the full year 2025?
A：China's beauty retail sales grew by 8.2% in the fourth quarter and by 5.1% for the full year 2025.
Q：What were the improvements in profitability for the fourth quarter and the full year 2025?
A：The net income improved record-wise in the fourth quarter under both GAAP and non GAAP measures. For the full year 2025, the company narrowed the net loss margin to 2.2% from 29% in the prior year while delivering a non-GAAP profitability margin of 0.2%.
Q：What are the key drivers of growth for the full year 2025?
A：The key drivers of growth for the full year 2025 were color cosmetics and skincare brands, with the latter contributing 50% of the total net revenues.
Q：How has the company focused on innovation and brand equity?
A：The company leveraged an established RD infrastructure for product innovation using proprietary ingredients, open collaboration, and AI, and strengthened brand equity across a multi-brand portfolio.
Q：What are the details of the launches by GANIC in 2025?
A：GANIC launched the VB SN in September, further strengthening its cellular-level skincare framework, and introduced the Code 2 Revelation Cellular Revising Cream in December, which won the breakthrough repair ceremony at the 2020 two-five cosmobiology of awards.
Q：How has the company addressed the evolving needs of diverse consumer segments?
A：The company has maintained a comprehensive view of the beauty industry, leveraging expertise and trends to precisely address the needs of various consumer segments, as exemplified by the launch of PR in Thein from the brand doctor Wu.
Q：What strategies are in place to enhance profitability and operational excellence?
A：The company is optimizing product mix, prioritizing high-margin products, enhancing marketing efficiency, and cost-optimizing operations to gain operational leverage and deliver steady margin expansion.
Q：What is the company's commitment moving forward?
A：The company will stay committed to long-term brand equity through innovation and delivering quality-focused, customer-centric growth.
Q：What is the decrease in general and administrative expenses for the fourth quarter of 2025 compared to the prior year period?
A：General and administrative expenses for the fourth quarter of 2025 decreased to 5.4% from 8.7% for the prior year period.
Q：What is the non-GAAP net income for the fourth quarter of 2025 compared to the prior year period?
A：Non-GAAP net income for the fourth quarter of 2025 was 41.2 million as compared with a loss of 9.3 million for the prior year period.
Q：What are the highlights of the company's full year results for 2025?
A：For the full year of 2025, total net revenues increased by 26.7%, gross profit increased by 28.4%, and the gross margin increased to 73.2%. Full year 2025 operating loss was 185.8 million, a decrease from 824.9 million in the prior year period, primarily because there was no impairment of goodwill. Non-GAAP loss from operations for the full year was 503 million, and the non-GAAP operating loss margin decreased to 2% from 6.6% for the prior year period. Net loss for the full year of 2025 was 92.4 million, a decrease from 710.2 million in the prior year period, with a net loss margin of 2.2% as compared with 20.9% for the prior year period.
Q：What is the company's strategy for expanding its profit portfolio for skincare brands in the current year?
A：The company's strategy for expanding its profit portfolio for skincare brands in the current year relies heavily on continued investment in research and development (R&D). Over the past six years, the company has been investing aggressively in R&D capabilities. The phenomenal top-line growth of the skincare business in recent years has largely been attributed to the contributions of the R&D team in developing products that meet consumer demand.
Yatsen Holding Ltd.
Follow
